Human iPS cells
Based on many years of experience, we develop efficient and robust protocols for the differentiation of human induced pluripotent stem cells (hiPSCs) into different cell types. We use state-of-the-art technologies to characterize the cells at key stages of their differentiation. The focus is on establishing systematic and structured quality controls, optimized procedures for large-scale cell production and continuous improvement of differentiation protocols to obtain the desired cell type reproducibly and in high purity. Currently, our range includes hiPSC-derived cells of the three germ layers ectoderm, mesoderm and endoderm, for example haematopoietic progenitor cells, cardiac progenitor cells, neural progenitor cells, microglia, macrophages, cortical neurons, astrocytes and cardiomyocytes. 2D Alzheimer’s disease models are also available.
Do you need organoid-based disease models for cell therapy and drug discovery? After joint specification of the cell type or disease model, we can realize the project for you. We also offer this service in combination with genome editing. In collaboration with our specialists, you determine protocols and procedures for the production and complete characterisation and validation of the desired cell types.